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Abstract 
Background: Aldehyde‑deformylating oxygenase (ADO) is an important enzyme involved in the biosynthetic path‑
way of fatty alk(a/e)nes in cyanobacteria. However, ADO exhibits quite low chain‑length specificity with respect to 
the substrates ranging from C4 to C18 aldehydes, which is not suitable for producing fuels with different properties or 
different chain lengths.
Results: Based on the crystal structures of cADOs (cyanobacterial ADO) with substrate analogs bound, some amino 
acids affecting the substrate specificity of cADO were identified, including the amino acids close to the aldehyde 
group and the hydrophobic tail of the substrate and those along the substrate channel. Using site‑directed mutagen‑
esis, selected amino acids were replaced with bulky ones introducing steric hindrance to the binding pocket via 
large functional groups. All mutants were overexpressed, purified and kinetically characterized. All mutants, except 
F87Y, displayed dramatically reduced activity towards C14,16,18 aldehydes. Notably, the substrate preferences of some 
mutants towards different chain‑length substrates were enhanced: I24Y for n‑heptanal, I27F for n‑decanal and 
n‑dodecanal, V28F for n‑dodecanal, F87Y for n‑decanal, C70F for n‑hexanal, A118F for n‑butanal, A121F for C4,6,7 alde‑
hydes, V184F for n‑dodecanal and n‑decanal, M193Y for C6–10 aldehydes and L198F for C7–10 aldehydes. The impact of 
the engineered cADO mutants on the change of the hydrocarbon profile was demonstrated by co‑expressing acyl‑
ACP thioesterase BTE, fadD and V184F in E. coli, showing that n‑undecane was the main fatty alkane.
Conclusions: Some amino acids, which can control the chain‑length selectivity of substrates of cADO, were identi‑
fied. The substrate specificities of cADO were successfully changed through structure‑guided protein engineering, 
and some mutants displayed different chain‑length preference. The in vivo experiments of V184F in genetically engi‑
neered E. coli proved the importance of engineered cADOs on the distribution of the fatty alkane profile. The results 
would be helpful for the production of fatty alk(a/e)nes in cyanobacteria with different properties.
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Background
The biosynthesis of fatty alk(a/e)nes by plants, insects, 
birds, green algae and cyanobacteria has been attracting 
great attention, since fatty alk(a/e)nes have been consid-
ered as the ideal replacements for fossil-based fuels [1–5]. 
It has been accepted that one of the enzymatic pathways 
producing alk(a/e)nes is derived from fatty acyl-ACP or 
-CoA in a two-step reaction: fatty acyl-ACP or -CoA is 
first reduced into fatty aldehyde by acyl-ACP or -CoA 
reductase, then fatty aldehyde is converted into alk(a/e)
ne by aldehyde decarbonylase (now renamed as alde-
hyde-deformylating oxygenase, ADO). In 2010, Schirmer 
et al. identified two genes involved in alk(a/e)ne biosyn-
thesis in cyanobacteria: acyl-ACP reductase and ADO 
[1]. In 2013, Akhtar et al. reported that a carboxylic acid 
reductase (CAR) from Mycobacterium marinum could 
convert a wide range of aliphatic fatty acids (C6–C18) into 
corresponding aldehydes, which can then be transformed 
into fatty alkane by ADO [6]. From the viewpoint of 
chemistry, transformation of aldehydes into alk(a/e)nes 
by ADO is quite difficult and unusual, so cADO (cyano-
bacterial ADO) has attracted particular interest in indus-
try and academia [7].
Since then, several important conclusions have been 
drawn: (1) the C1-derived coproduct of the cADO-cata-
lyzed reaction is formate, instead of previously supposed 
carbon monoxide [8]; (2) oxygen is absolutely required, 
and one O-atom is incorporated into formate [9, 10]; 
(3) the auxiliary reducing system providing four elec-
trons is needed, and the homologous electron transfer 
system worked more effectively than the heterologous 
and chemical ones in supporting cADO activity [1, 9, 
11–13] (Scheme  1). It has been observed that self-suffi-
cient cADOs fused to homogenous ferredoxin (Fd) and 
ferredoxin-NADP+ reductase (FNR) could efficiently 
catalyze conversion of aldehydes into alk(a/e)ne [14]. 
Andre et  al. reported that cADO was reversibly inhib-
ited by H2O2 originating from poor coupling of reductant 
consumption with alk(a/e)ne formation, and the kinetics 
of cADO towards aldehyde substrates of carbon chain 
lengths between 8 and 18 carbons showed that cADO did 
not exhibit strong chain-length specificity with respect 
to its substrates [15]. cADO also produces n-1 aldehydes 
and alcohols in addition to alk(a/e)ne [16]. Mechanistic 
studies have demonstrated that a radical intermediate is 
involved in the cADO-catalyzed reaction, and a possible 
catalytic process has been proposed based on the crystal 
structures of cADO from Synechococcus elongatus strain 
PCC7942 [17–20]. cADO was engineered to improve 
specificity for short- to medium-chain aldehydes [21]. 
Hayashi et  al. investigated the role of three cysteines 
in the structure, stability and alk(a/e)ne production of 
cADO [22]. Based on the crystal structures of cADO, 
cADO belongs to the non-heme dinuclear iron oxyge-
nase family of enzymes including methane monoxyge-
nase, type I ribonucleotide reductase and ferritin [1, 17, 
23–25].
Fatty alk(a/e)nes are the main component of traditional 
fuels such as gasoline, diesel and jet fuel. The carbon 
number distribution of hydrocarbons varies in different 
fuels, for example, 4–12 in gasoline, 9–23 in diesel and 
8–16 in jet fuel [26]. Increasing interest in developing the 
next generation of biofuels, which can function as “drop-
in” fuels, has spurred high attention towards the enzymes 
involved in hydrocarbon biosynthesis. The acyl-ACP thi-
oesterases with different carbon chain-length specific-
ity could be used to synthesize the fatty acid-based fuels 
such as fatty alcohols and FAEs (fatty acid esters) with 
different carbon chain length distributions [27]. A num-
ber of different carbon chain length-specific acyl-ACP 
thioesterases have been successfully utilized to control 
the carbon chain length distributions of fatty acids and/or 
fatty acid derivatives in genetically engineered microbes, 
such as tesA from Escherichia coli (C16:0), CCTE from 
Cinnamomum camphora (C14:0), and BTE from Umbel-
lularia californica (C12:0) [28]. Moreover, engineering 
efforts have also been successful in altering the specificity 
of wild-type desaturases, such as the Castor Δ9-18:0-ACP 
desaturase, leading to the isolation of mutants with up 
to 15-fold increased specific activity towards 16-carbon 
substrates [29]. The substrate specificity of β-ketoacyl-
ACP synthase was modified from 8:0-ACP substrate to 
6:0-ACP through protein engineering [30]. Very recently, 
an acyl carrier protein (ACP) from Synechococcus elonga-
tuswas engineered to enhance production of shortened 
fatty acids such as C14 fatty acid [31].
Alternatively, structure-orientated substrate specific-
ity engineering of cADO would also facilitate produc-
tion of these “drop in” biofuels with different carbon 
chain-length distributions. However, it was observed that 
cADO-PMT1231 from Prochlorococcus marinus (strain 
MIT9313) exhibits quite low chain-length specificity (C4–
18) with respect to the aldehyde substrates [15]. Given 
that all cADOs showed similar structural characteristics 
(structural superimposition of cADO-1593 and cADO-
PMT1231) (Additional file  1: Figure S1), the cADO 
enzymes from different cyanobacterial species might 
have similar substrate profiles. Therefore, the available 
crystal structures of cADOs with the bound substrate Scheme 1 cADO‑catalyzed reaction [8–10]
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analogs such as fatty acids or fatty alcohols or fatty alde-
hydes have enabled structure-guided substrate specificity 
engineering of cADOs [1, 17, 21, 23].
In this current study, the amino acids of cADO-1593 
from Synechococcus elongatus which might influence 
the chain-length selectivity of the substrates were iden-
tified and fully characterized. The substrate specificities 
of cADO towards different chain-length substrates were 
achieved through structure-orientated engineering, and 
in vivo experiments were also performed by introducing 
an engineered ADO mutant into a fatty alk(a/e)ne pro-
ducing E. coli factory.
Results
Identification of the amino acids that may influence the 
substrate specificity of cADO
According to the crystal structure of cADO-1593 from 
Synechococcus elongatus strain PCC7942 (PDB code: 
4RC5) [17], amino acids involved in the substrate chan-
nel were identified, including Tyr21, Ile24, Ile27, Val28, 
Gly31, Phe67, Cys70, Phe86, Phe87, Phe117, Ala118, 
A121, Tyr122, Tyr125, Val184, Met193 and Leu198 
(Fig.  1). Since the side chains of Phe67, Phe86, Phe117, 
Tyr122 and Tyr125 are either parallel with the substrate 
analog or do not point towards the substrate analog and 
only provide a hydrophobic environment for the sub-
strate, they are not investigated in the current study. The 
other amino acids, which might have some influence on 
the substrate specificity of cADO, were investigated.
Investigation into the substrate tunnel of cADO-1593 
revealed that the amino acids, Gly31 and Ala118 are close 
to the di-iron center and the aldehyde group of the sub-
strate (<C4). Replacement of these two amino acids with 
tyrosine or phenylalanine, which may introduce a steric 
block in this position, might improve the selectivity of 
cADO for short-chain substrates against medium- and 
long-chain substrates.
Amino acids including Ile24, Ile27, Val28, Phe87, 
Ala121, Val184 and Leu198 were also identified along 
the substrate tunnel. All of them point their side chains 
towards the bound substrates and their side chains are 
approximately perpendicular to the substrate. Both Val41 
and Ala134 of cADO PMT1231 from Prochlorococ-
cus marinus (MIT9313) [21] have been shown to have 
effects on substrate specificity, which are, respectively 
equivalent to the sites of Val28 and Ala121 of cADO-
1593. These amino acids might also have some impact on 
access of medium and long-chain length substrates when 
they are replaced with bulky ones, such as tyrosine or 
phenylalanine.
The amino acids Tyr21 and Cys70 are situated close to 
the hydrophobic end of the substrate analog according to 
the crystal structure of cADO-1593, which was predicted 
to be the possible substrate entrance. Therefore, muta-
tion of them into the bulky ones might have some influ-
ence on substrate entry.
Site‑directed mutagenesis, overexpression, purification 
and enzymatic assays of WT and cADO mutants
Considering that replacement of the above identified 
amino acids with large ones might impede the binding of 
substrates beyond certain length or substrate access, thir-
teen mutants, including Y21R, I24Y, I27F, V28Y, G31F, 
C70F, F87Y, A118F, A121F, V184F, M193Y and L198F, 
were constructed following the standard protocol using 
WT cADO-1593 as the template. All mutants were suc-
cessfully overexpressed in E. coli BL21(DE3) and purified 
on a nickel column as previous described [13] (Additional 
file  2: Figure S2). All enzymatic assays were carried out 
in the presence of the chemical reducing system NADH/
PMS (phenazine methosulfate) and catalase [13].
Activities towards medium‑to long‑chain length aldehydes
Medium- and long-chain (C10,12,14,16,18) aldehydes were 
used as the substrates to investigate the effects of the 
mutations on the substrate specificity (Fig. 2; Additional 
file 3). A118F did not show any obvious activity against 
C14,16,18 aldehydes, and only exhibited slight activity 
towards n-dodecanal and n-decanal. Eleven mutants, 
excluding F87Y, displayed dramatically reduced activ-
ity towards C14,16,18 aldehydes. Notably, the activities 
Fig. 1 Identified residues which might affect the substrate specificity 
of cADO (PDB code: 4RC5). The identified residues include those close 
to the aldehyde group (Gly31 and Ala118) and the hydrophobic tail 
(Tyr21 and Cys70) of the substrate, and those along the substrate 
channel (Ile24, Ile27, Val28, Phe87, Ala121, Val184, Met193 and 
Leu198). The bound substrate analog was colored yellow
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of V184F (4.4-fold), F87Y (2.5-fold), I27F (2.1-fold) 
and V28Y (2.0-fold) towards n-dodecanal were greatly 
enhanced. G31F, A121F and M193Y exhibited compara-
ble activity to WT towards n-dodecanal, and Y21R and 
I24Y displayed low activities towards n-dodecanal and 
n-decanal. Different behavior against n-decanal for I27F 
and V28Y were observed: improved activity for I27F and 
reduced activity for V28Y. C70F exhibited comparable 
activities to WT towards n-dodecanal and n-decanal. 
L198F showed reduced activity against n-dodecanal, but 
improved activity for n-decanal (1.4-fold). The activi-
ties of A121F, V184F and M193Y for n-decanal were 
improved. F87Y showed enhanced activity against 
n-decanal (1.8-fold) and similar activity to WT towards 
n-octadecanal.
Activities towards medium‑ to short‑chain aldehydes
a. Apparent kcat values of WT cADO and mutants 
towards n‑heptanal
n-Heptanal has been successfully used as the substrate 
to determine the apparent kcat values of cADOs, and was 
utilized to examine whether the kinetics of the mutants 
were influenced (Fig. 2) [12–14]. The apparent kcat value 
of M193Y was improved by about three-fold in compari-
son with that of WT, and was the highest one among all 
mutants. Compared with WT, the apparent kcat values 
of L198F, I24Y and A121F were increased by two-fold, 
and C70F, Y21R, F87Y, V184F and G31F exhibited the 
comparable apparent kcat values to WT, demonstrating 
that these mutations had little influence on the activi-
ties towards n-heptanal. The activities of I27F, V28Y and 
A118F were severely impaired.
b. Kinetic characterization of WT cADO and some mutants 
towards C6–9 aldehydes
C6,8,9 aldehydes were also used as the substrates to inves-
tigate the effects of some mutations on chain-length 
selectivity (Fig. 3). In comparison with WT, A121F, C70F, 
M193Y and L198F showed 2.7, 2.5, 1.7 and 1.4–fold 
increase in kcatapp against n-hexanal, respectively, and I24Y 
demonstrated similar kcatapp for n-hexanal. When n-octa-
nal was used as the substrate, M193Y (3.2-fold) showed 
significantly improved activity, and A121F and L198F 
exhibited comparable activity to WT, and I24Y and C70F 
displayed much lower activity (Fig. 3b). While n-nonanal 
was used as the substrate, M193Y and L198F exhibited 
1.7 and 2.0-fold increase in kcatapp respectively, and the 
apparent kcat value of I24Y was much lower than that of 
WT, and those of C70F and A121F were about half of 
that of WT.
According to the published results by Khara et  al. 
for cADO-PMT1231 from Prochlorococcus marinus 
(strain MIT9313), A134F, which is equivalent to A121F 
of cADO-1393, showed significantly improved activ-
ity against C6,7,8 aldehydes [21]. Therefore, the kinetic 
parameters of A121F against C6–9 aldehydes were deter-
mined in detail (Additional file 4). The kinetic parameters 
of A121F and WT cADO-1593 are listed in Table  1. In 
comparison with WT, A121F exhibited one-fold increase 
in the Km value for n-nonanal and similar Km value for 
other substrates. It seems that the Km values of WT and 
A121F towards C6–9 aldehydes decrease with increas-
ing chain-length of the substrates. This mutant dis-
played higher kcat values for C6,7 aldehydes, but similar 
values against C8,9 aldehydes. The kcat value of A121F 
towards n-hexanal was the highest among the substrates 
tested. Compared with WT, A121F showed significantly 
improved catalytic efficiency (kcat/Km) against n-hexanal 
and slightly higher one for n-heptanal. The catalytic effi-
ciencies of WT towards C8,9 aldehydes are much higher 
than that of A121F for n-hexanal, which could be mainly 
caused by the big difference in Km between them.
c. Apparent kcat values of WT cADOs and several mutants 
towards n‑butanal
Since Gly31 and Ala118 are very close to the aldehyde 
group of the substrate, it is expected that G31F and 
A118F may exhibit inhibition against short aldehydes 
such as n-butanal than WT (Fig.  3d). In comparison 
with WT cADO-1593, the apparent kcat value of A118F 
towards n-butanal was improved by 2.2-fold, whereas 
G31F showed greatly decreased activity for n-buta-
nal (data not shown) (Fig.  3d). Considering that large 
Phe might have negative effects on activity, A118L was 
also constructed. Unexpectedly, A118L gave the same 
result as A118F). A121F exhibited the highest kcatapp value 
towards n-butanal (3.3-fold increase).
Further characterization of WT and some cADO mutants
a. Circular dichroism (CD) for WT cADO and some mutants
CD was used to investigate the effects of mutations on 
the conformational or structural changes. All mutants 
displayed similar CD spectroscopies to WT (Fig. 4), and 
secondary structures of WT cADO and all mutants were 
(See figure on next page.) 
Fig. 2 Yields of fatty alkanes for wild‑type cADO and variants towards C10,12,14,16,18 aldehydes (a– c) and the apparent kcat values towards n‑heptanal 
(d). Yields of fatty alkanes for wild‑type cADO and variants towards C10,12,14,16,18 aldehydes were determined by GC–MS and using C20 alkane (10 μM) 
as an internal standard. The amount of n‑hexane produced was quantified by GC and a standard curve of known concentrations of n‑hexane
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also very close (Additional file 5: Table S1). These results 
indicated that mutations did not lead to significant con-
formational changes for these mutants. Thus, the reasons 
why mutants showed different behavior (activities and/or 
chain length selectivity) from WT are due to the change 
of the side chains of amino acids instead of conforma-
tional or structural changes.
b. Mixed‑substrate competition assays for WT and some 
cADO mutants
Based on the results of all mutants towards different 
chain-length substrates, it seems that mutants showed 
different chain length preference, for example, I24Y for 
n-heptanal, I27F for n-decanal and n-dodecanal, V28F 
for n-dodecanal, F87Y for n-decanal, C70F for n-hexanal, 
A118F for n-butanal, A121F for C4,6,7 aldehydes, V184F 
Fig. 3 Apparent kcat values of WT and variants towards n‑nonanal (a), n‑octanal (b), n‑hexanal (c), and n‑butanal (d). The amounts of n‑octane, 
n‑heptane, n‑pentane, and n‑propane produced were quantified by GC and a standard curve of known concentrations of the same product
Table 1 Kinetic parameters of  wild-type cADO and  A121F 
towards C6–9 aldehydes




 WT 0.93 ± 0.1 1.8 ± 0.1 1.9 ± 0.1
 A121F 0.96 ± 0.05 6.9 ± 0.2 7.2 ± 0.3
C7
 WT 0.59 ± 0.07 0.79 ± 0.03 1.3 ± 0.1
 A121F 0.56 ± 0.06 1.5 ± 0.1 2.7 ± 0.2
C8
 WT 0.18 ± 0.03 1.4 ± 0.06 7.8 ± 0.3
 A121F 0.18 ± 0.036 0.98 ± 0.06 5.4 ± 0.3
C9
 WT 0.069 ± 0.0087 0.61 ± 0.02 9.0 ± 0.5
 A121F 0.14 ± 0.022 0.77 ± 0.04 5.4 ± 0.3
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for n-dodecanal and n-decanal, M193Y for C6–10 alde-
hydes and L198F for C7–10 aldehydes. To further con-
firm the impact of mutations on chain length selectivity 
of cADO, the mixed-substrate competition assays were 
carried out for some mutants. While the preferred chain-
length substrates of mutants were used, enzymatic activi-
ties of mutants were assayed in the presence of a short 
chain length substrate (n-butanal/n-heptanal/n-nonanal) 
and a long one (n-octadecanal), respectively.
When WT ADO was assayed against n-heptanal in the 
presence of the competition substrates n-butanal and 
n-octadecanal, respectively, both did not show obvious 
inhibition (Table  2). However, under same conditions, 
inhibition was observed for A121F towards n-heptanal 
in the presence of n-butanal and n-octadecanal. In con-
trast, n-butanal did not exhibit inhibition for I24Y against 
n-heptanal, whereas n-octadecanal displayed some inhi-
bition. While n-octanal was used as the substrate, WT 
and M193Y demonstrated similar behavior to A121F 
in the presence of the competition substrates. WT and 
L198F performed differently in the presence of n-butanal 
using n-nonanal as the substrate: it did not inhibit WT, 
but inhibited L198F, whereas both could be inhibited by 
n-octadecanal.
When WT ADO, F87Y and I27F were assayed against 
n-dodecanal in the presence of n-heptanal and n-octa-
decanal, respectively, both exhibited inhibition for three 
enzymes to different extent (Table  3). In contrast, for 
Fig. 4 Circular dichroism (CD) spectra for WT cADO and some mutants. Far‑UV CD spectra (190–260 nm) were recorded for protein samples 
(0.12 mg/mL) in 10 mM potassium phosphate buffer (pH 7.2) on a Jasco J‑810 spectropolarimeter at 25 °C. Data were averaged over three runs and 
the background was subtracted
Table 2 Apparent kcat values of  some cADO mutants 
and  WT against  the preferred substrates in  the presence 
of the competition substrates
The apparent kcat values of some cADO mutants and WT against the preferred 
substrates (2 mM C7,8,9 aldehydes) in the presence of the competition substrates 
(2 mM n-butanal or 150 μM n-octadecanal) were determined, respectively
Mutants Preferred/competition aldehydes kcat
app (min−1)
WT C7 0.80 ± 0.086
C7/C4 0.80 ± 0.079
C7/C18 0.77 ± 0.14
A121F C7 1.41 ± 0.036
C7/C4 0.75 ± 0.093
C7/C18 0.69 ± 0.01
I24Y C7 1.05 ± 0.076
C7/C4 0.82 ± 0.024
C7/C18 0.39 ± 0.026
WT C8 0.33 ± 0.064
C8/C4 0.35 ± 0.057
C8/C18 0.24 ± 0.017
M193Y C8 1.05 ± 0.20
C8/C4 1.05 ± 0.18
C8/C18 0.52 ± 0.032
WT C9 0.24 ± 0.021
C9/C4 0.23 ± 0.025
C9/C18 0.18 ± 0.023
L198F C9 0.50 ± 0.024
C9/C4 0.25 ± 0.076
C9/C18 0.25 ± 0.015
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V184F and V28Y, n-heptanal displayed some inhibition, 
whereas n-octadecanal did not.
Impact of engineered cADOs on distribution of fatty 
alkane profile in an E. coli cell factory
To demonstrate the importance of engineered ADO 
mutants on distribution of fatty alkane profile in  vivo, 
V184F showing the highest activity for n-dodecanal was 
introduced into an engineered E. coli which can produce 
high titers of n-dodecanoic acid [28].
It is known that the fatty acid intermediate, such as 
fatty acyl-ACP or acyl–CoA, could be reduced by acyl-
ACP or -CoA reductase into fatty aldehyde, which is 
further converted into fatty alk(a/e)ne by cADO [1]. 
Therefore, enhancing production of FFAs with certain 
chain-lengths is quite essential for fatty alk(a/e)ne pro-
duction in genetically engineered E. coli [32]. To achieve 
this, the following strategies were used: (1) The gene 
fadE was knocked out, which can accumulate fatty acyl-
CoA by blocking the fatty acid degradation pathway. (2) 
The gene fadD (an acyl-CoA synthetase) from E. coli 
was overexpressed to further boost fatty acyl-CoA yield. 
(3) The gene BTE encoding Cinnamomum camphora 
acyl-ACP thioesterase B was overexpressed to increase 
the abundance of medium-chain free fatty acids such as 
dodecanoic acid. (4) The gene acr1 encoding fatty acyl-
CoA reductase (FAR) from Acinetobacter sp. M-1 was 
overexpressed to reduce the accumulated fatty acyl-CoA 
into the corresponding fatty aldehyde. (5) Wild-type 
cADO or the mutant V184F was overexpressed to pro-
duce fatty alk(a/e)nes. The effects of overexpression of 
wild-type cADO and V184F on fatty alk(a/e)ne produc-
tion in recombinant strain of E. coli BL21 (DE3) (ΔfadE) 
carrying BTE and fadD were investigated.
For the control strain, BL21 (ΔfadE), n-palmitic acid 
(C16:0) and n-steric acid (C18:0) were major FFAs (95  %) 
produced, together with trace quantities of n-dodecanoic 
acid (C12:0) and n-tetradecanoic acid (C14:0) (Table 4). The 
titers of n-dodecanoic acid of the recombinant strain of 
LB99 (co-expression of BTE and fadD) were improved 
by 5.5-fold compared to the control strain, while those of 
n-tetradecanoic acid, n-palmitic acid and steric acid were 
significantly reduced by 0.43-fold, 7.5-fold, and 23-fold, 
respectively (Table  5). A large quantity of n-dodecanol 
was also detected in LB99, which could be caused by 
some endogenous reductases in E. coli [33]. The engi-
neered strains LB100 (co-expression of BTE, fadD, and 
wild-type cADO gene) and LB101 (co-expression of BTE, 
fadD, and cADO mutant V184F gene) produced similar 
titers of n-dodecanoic acid, which were higher than that 
of the control strain and lower than that of LB99. These 
results indicated that co-overexpression of fad and BTE 
dramatically improved the titers of n-dodecanoic acid in 
BL21 (ΔfadE).
No fatty alk(a/e)nes were detected in BL21 (ΔfadE) 
and engineered strain LB99, but about 0.72  mg/L/OD 
n-dodecanol was detected in LB99 cultures. LB100 pro-
duced 0.044  mg/L/OD n-undecane, 0.066  mg/L/OD 
n-pentadecane and 0.3  mg/L/OD 8-heptadecene. Com-
pared to LB100, LB101 produced improved titers of 
n-undecane (1.7-fold) and significantly reduced titers of 
Table 3 Yields of  n-undecane of  WT and  some cADO 
mutants against  n-dodecanal in  the presence of  the com-
petition substrates
Yields of n-undecane of WT and some cADO mutants against n-dodecanal 
(150 μM) in the presence of the competition substrates (2 mM n-heptanal or 
150 μM n-octadecanal) were determined by GC–MS
Mutants Yield of n‑undecane (μM)
C12 C12/C7 C12/C18
WT 1.95 ± 0.13 1.55 ± 0.12 1.61 ± 0.064
V184F 8.65 ± 0.0.28 4.04 ± 0.35 9.75 ± 0.038
F87Y 3.01 ± 0.0043 1.74 ± 0.16 1.50 ± 0.0091
I27F 4.30 ± 0.13 1.91 ± 0.061 2.27 ± 0.11
V28Y 3.51 ± 0.12 1.78 ± 0.31 3.19 ± 0.39
Table 4 Fatty alk(a/e)ne production in genetically engineered E. coli strains
Yields of fatty alk(a/e)nes and others produced by genetically engineered E. coli strains were quantified by GC–MS
ND not determined due to low concentrations
mg/L/OD ΔfadE (BL21) LB99 LB100 LB101
n‑Undecane ND ND 0.044 ± 0.0030 0.078 ± 0.0010
n‑Pentadecane ND ND 0.066 ± 0.011 0.016 ± 0.0028
8‑Heptadecene ND ND 0.30 ± 0.023 ND
n‑Dodecanol ND 0.72 ± 0.0035 ND ND
n‑Dodecanoic acid 0.16 ± 0.014 1.1 ± 0.12 0.41 ± 0.039 0.50 ± 0.060
n‑Tetradecanoic acid 1.43 ± 0.050 1.0 ± 0.015 1.0 ± 0.16 0.95 ± 0.055
n‑Hexadecanoic acid 15.1 ± 2.1 1.8 ± 0.030 2.8 ± 0.32 4.1 ± 0.27
n‑Octadecanoic acid 14.9 ± 1.6 0.62 ± 0.025 1.1 ± 0.12 0.67 ± 0.077
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n-pentadecane (0.24-fold). In addition, no 8-heptadecene 
was detected in LB101 cultures (Additional file 6: Figure 
S3).
Discussion
The carbon number distribution of fatty alk(a/e)nes var-
ies in different fuels such as gasoline, diesel and jet fuel, 
and has important effects on the properties of fuels. 
Therefore, it’s significant to genetically control the car-
bon chain-length of microbial hydrocarbons [27]. The 
available crystal structures of cADOs with fatty acids 
or fatty alcohol or substrate analog bound have enabled 
structure-guided substrate specificity engineering of 
cADO [1, 17, 21, 23]. In this current paper, we have iden-
tified some potential amino acids which might impact 
the substrate chain-length specificity of cADO through 
structural analysis of cADOs. All selected amino acids 
are adjacent to the aldehyde group and the hydrophobic 
tail of the substrate and along the substrate pocket. We 
hypothesized that the chain-length selectivity of cADO 
might be changed or at least substrate access would be 
influenced when these amino acids were replaced with 
the large ones.
All mutants except F87Y showed greatly reduced or no 
activity (A118F) towards long-chain aldehydes (C14,16,18), 
and demonstrated preference against <C14 aldehydes, 
supporting our hypothesis that replacement of the amino 
acids with the large ones resulted in hindering access of 
long-chain substrates (≥C14) (Figs. 2, 3). The results are 
consistent with the relative positions of these amino 
acids in the crystal structure along the substrate channel 
(Fig. 1). Therefore, the size of the hydrophobic channel of 
the substrate was successfully decreased. Most of these 
amino acids could be useful for engineering cADO to 
synthesize fatty alk(a/e)nes (<C13).
Gly31 and Ala118 are close to the aldehyde group of the 
substrate. According to the predicted orientation of the 
side chains of G31F and A118F by PyMOL (Additional 
file 7: Figure S4), both mutants present their side chains 
approximately towards the C4 position of the bound 
ligand, consistent with their performance against C14,16,18 
aldehydes. However, they performed differently towards 
other substrates such as C4,7,12 aldehydes. The results are 
not in agreement with the expected orientation of the 
side chains of G31F and A118F (Additional file 7: Figure 
S4). A118F had significant effects on substrate specific-
ity, whereas G31F did not. Considering the relative posi-
tion and the different performance of G31F and A118F, 
it appears that amino acid 31 is in a more flexible posi-
tion than amino acid 118. To achieve propane production 
by cyanobacteria, Ala118 is a good candidate for further 
protein engineering.
In the case of the mutants of the amino acids along 
the substrate channel, including I24Y, I27F, V28Y, F87Y, 
A121F, V184F, M193Y and L198F, they behaved differ-
ently, and were discussed according to their relative posi-
tions to the bound substrate analog: (1) Phe87 protrudes 
the side chain to the C5 position. Given the small differ-
ence between the side chains of Phe and Tyr, it is under-
standable that introducing an additional hydroxyl group 
might not have big impact on substrate specificity and 
activity, except for n-dodecanal (2.5-fold improvement). 
(2) Ile27 and Val28 are in the relatively similar position, 
presenting their side chains towards the C7–C8 position 
of the substrate analog. However, the results demon-
strated that mutation of them into the large ones caused 
some steric hindrance for long-chain substrates (≥C14), 
and the activities of I27F and V28Y against n-dodecanal 
are about twofold higher than that of WT. Khara et  al. 
reported the similar results for V41Y (the counterpart 
of V28Y of cADO-1593) and WT of cADO-PMT1231 
against the substrates with different chain-lengths [21]. 
(3) Though the side chains of both Val184 and Leu198 
points towards the C9–C10 position, V184F and L198F 
performed differently. Mutation of Leu198 into large Phe 
might have negative impact on substrate binding (>C9 
Table 5 Detailed information on the plasmids and strains used
Plasmids or strains Relevant characteristics Reference
pET‑28a Kanr; pBR322 ori; lacI; T7 promoter Novagen
pAL134 Kanr; pET‑28b derivative containing acr1 gene; T7 promoter [34]
pKC11 Apr; pFN476 derivative containing E. coli fadD; BAD promoter [34]
pLB1593‑acr1 Kanr; pET‑28a derivative containing acr1 and wild‑type cADO gene; T7 promoter This study
pLB1593‑V184F‑acr1 Kanr; pET‑28a derivative containing acr1 and cADO mutant V184F gene; T7 promoter This study
BL21 (ΔfadE) BL21 (DE3) knocking out fadE [33]
LB99 BL21 (ΔfadE) bearing pAL134 and pKC11 This study
LB100 BL21 (ΔfadE) bearing pAL134, pKC11 and pLB1593‑acrI This study
LB101 BL21 (ΔfadE) bearing pAL134, pKC11 and pLB1593‑V184F‑acrI This study
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aldehydes). The results are consistent with the expec-
tation: L198F exhibited dramatically reduced activity 
towards n-dodecanal and higher chain-length selectivity 
against aldehydes (≤C10), especially for n-heptanal. By 
contrast, substitution of Val184 by large Phe resulted in 
hindered access of long chain-length substrates (≥C14). 
V184F showed significantly improved activity towards 
n-dodecanal (the highest among all mutants) and similar 
activity to WT for n-heptanal. Though both Leu198 and 
Val184 present the side chains towards the similar posi-
tion of the substrate, V184F and L198F demonstrated 
different behavior (chain length preference), especially 
towards n-dodecanal. (4) Mutagenesis of Ala121 into Phe 
blocked access of long-chain length aldehydes (>C12). The 
side chain of Ala121 points approximately towards the 
C10–C11 position of the substrate analog, which is con-
sistent with the substrate selectivity of A121F. The results 
of A121F against the tested substrates are very similar to 
those of A134F of PMT1231 (corresponding to A121F of 
cADO-1593), and further proved the significance of this 
amino acid for improving the chain-length selectivity of 
cADO. A121F showed preference towards ≤C12 alde-
hydes, higher preference for C4,6,7 aldehydes and highest 
for n-hexanal (Figs. 2, 3; Table 1). The results suggested 
that A121F exerted great effects on both substrate prefer-
ence and activity. (5) Ile24 presents the side chain towards 
the C12–C13 position, and the results indicated that muta-
tion of Ile24 into large Tyr affected access of medium to 
long-chain length substrates (≥C9). I24Y showed higher 
preference for n-heptanal. (6) The side chain of Met193 
points to the C13–C14 position, thus mutation of Met193 
into large Tyr could lead to hinder binding of aldehydes 
(>C12) to enzymes. M193Y showed the highest activity 
against n-heptanal. Finally, it is worth pointing out that 
the inconsistency between predicted and actual chain-
length selectivity was observed for some mutants such as 
I27F, V28Y, V184F, I24Y and M193Y.
Tyr21 and Cys70 are close to the hydrophobic tail of 
the substrate. Mutation of Tyr21 into long and hydro-
philic Arg impeded access to long chain-length aldehydes 
(≥C12), whereas replacement of Cys70 with large Phe 
hindered access of long chain-length aldehydes (>C12) 
(Figs.  2, 3). Y21R did not show any preference towards 
tested substrates, whereas C70F displayed highest activ-
ity for n-hexanal. It has been reported that C71A/S 
(Cys71, equivalent to Cys70 of cADO-1593) of cADO 
from Nostoc punctiforme PCC 73102 reduced the hydro-
carbon producing activity of cADO and facilitated the 
formation of a dimer [22]. Based on the results and the 
positions of Tyr21 and Cys70 in the crystal structure, we 
predicted that both amino acids are possibly involved in 
the substrate entrance. However, according to the crystal 
structure of the complex of PMT1231 with the substrate 
(11-(2-(2-Ethoxyethoxy)ethoxy)undecanal) (PDB code: 
4PGI, L194A of PMT1231 complexed with the substrate), 
Marsh et al, observed a T-shaped region of electron den-
sity for the bound substrate, and suggested that the fork 
of exiting close to Leu194 of PMT1231 might be the sub-
strate entry point (Additional file 8: Figure S5) [23]. Our 
results seem not to support this. Meanwhile, Marsh et al, 
found that L194A of PMT1231 had similar kinetic prop-
erties to WT implying that L194A does not play a key 
role in limiting substrate access to the active site. Thus, 
the fork of the T-shaped region for the complexed sub-
strate occupying the cavity to bind fatty acids is the pos-
sible substrate entry point.
Substrate competition experiments reflected the dif-
ferent binding affinities between the preferred and com-
petition substrates (Tables 2, 3). It seems that WT binds 
to n-octadecanal more tightly than to n-butanal and WT 
showed different binding affinities towards C7,8,9 alde-
hydes, which are consistent with the corresponding Km 
values of WT against them (Tables 1, 2, 3). The results of 
A121F and L198F suggested that both mutants showed 
improved binding affinities towards n-octadecanal and 
n-butanal. In comparison, the competition results of I24Y 
and M193Y indicated that enhanced binding affinities 
towards n-octadecanal were observed for them and those 
against n-butanal did not change a lot. While n-dodeca-
nal was used as the preferred substrate in the presence 
of the competition substrates n-octadecanal and n-hep-
tanal, similar conclusions were drawn. Enhanced bind-
ing affinities against n-octadecanal and n-heptanal for 
F87Y and I27F were observed. V184F and V28Y showed 
increased binding affinities towards n-heptanal, and the 
binding affinities of V184F and V28Y for n-octadecanal 
were not changed.
As discussed above, all mutants except F87Y exhib-
ited lower activities against C18,16,14 aldehydes than WT 
(Fig.  2a, b), whereas V184F showed the highest activ-
ity for n-dodecanal among all mutants and comparable 
activity to WT towards n-heptanal (Fig. 2c, d). It seems 
that the replacement of Val184 with Phe had important 
effects on substrate binding with chain-length prefer-
ence, but no big influence on enzymatic activity. There-
fore, V184F was chosen for further investigation. It was 
introduced into engineered E. coli producing high titer 
of n-dodecanoic acid to see if the carbon chain-length 
selectivity of cADO mutants could be used to control 
the carbon chain-length distribution of fatty alk(a/e)nes 
in vivo [28]. The results of fatty alk(a/e)ne production in 
genetically engineered E. coli suggested that cADO was 
successfully engineered for n-undecane production in E. 
coli and introduction of the mutant V184F had significant 
influence on distribution of fatty alk(a/e)ne profile in E. 
coli (Table 4). Thus, V184F could be potentially used for 
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n-undecane production by genetically engineered micro-
bial cell factories in future.
Conclusions
Some amino acids, which could affect the substrate 
specificity of cADO were identified based on the crystal 
structure of cADO with the bound substrate analogs and 
kinetically characterized. The substrate preferences of 
some mutants towards different chain-length substrates 
were successfully enhanced through structure-orientated 
protein engineering. The in vivo experiments of V184F in 
genetically engineered E. coli demonstrated the impact 
of structure-guided engineering of cADOs on the dis-
tribution of the fatty alk(a/e)ne profile. The study would 
deepen our understanding of the structure–function 
relationship of cADOs, and provide a guide for design-




Oligonucleotide synthesis and DNA sequencing were 
carried out by Sangon Biotech Co. Ltd (Shanghai, China) 
or Sunny (Shanghai, China). The codon-optimized Syn-
pcc7942_1593 encoding ADO from Synechococcus elon-
gatus PCC7942 was synthesized by Sangon Biotech Co. 
Ltd). Pfu DNA polymerases and DpnI were from Fermen-
tas (Pittsburgh, Pennsylvania, USA). The kits used for 
molecular cloning were purchased from Omega (USA) or 
Takara (Japan). n-Butanal, C6–10 aldehydes, n-dodecanal, 
C14,16,18 alcohols, Dess-Martin reagent, n-pentadecanol, 
n-eicosane, n-heptadecanoic acid, BSA (Bovine Serum 
Albumin), NADH, catalase, DMSO, phenazine metho-
sulfate (PMS), NTA (Nitrilotriacetic acid) and ferrous 
ammonium sulfate were obtained from Sigma-Aldrich. 
Nickel column was from Novagen. Amicon YM10 mem-
brane was from Millipore.
Bacterial strains, plasmids and media
E.coli DH5α and BL21(DE3) were, respectively used for 
routine DNA cloning and protein expression. E. coli 
strains were grown in LB broth or terrific broth media 
containing antibiotics at standard concentrations. 50 μg/
mL Kanamycin was added when required.
E. coli BL21 (ΔfadE) was used as host cells for fatty 
alk(a/e)ne production [34]. Plasmid pAL143 expressing 
acyl-ACP thioesterase BTE from Cinnamomum cam-
phora with PBAD promoter was utilized to overproduce 
free fatty acid (C12:0) in the host cells [35]. Plasmid 
pKC11 encoding E. coli fadD gene with pSC101 ori-
gin was employed to overexpress an acyl-CoA synthase 
and block β-oxidation pathway [35]. To co-express acr1, 
a fatty acyl-CoA reductase and pET-28a-1593 (or pET-
28a-1593-V184F), the Bgl II-Spe I double-digested DNA 
fragment of pAL134 was inserted into pET-28a-1593 
cut by Bgl II and Xba I, resulting in pLB1593-acr1 (or 
pLB1593-V184F-acr1) [35]. Engineered E. coli strains 
were constructed by transformation BL21 (ΔfadE) with 
the plasmids in Table 5.
Construction of site‑directed mutants
General molecular biology techniques were carried out 
by standard procedures [36]. Plasmid DNA was isolated 
using the Plasmid Mini Kit I. Site-directed mutants were 
constructed according to the standard QuikChange Site-
Directed Mutagenesis protocol (Stratagene Ltd, La Jolla, 
California, USA) using pET28a-1593 as a template and 
the primers listed in Table S1 (Additional file  9: Table 
S2). The required mutations were confirmed by DNA 
sequencing.
For construction of double/triple/multiple mutants, 
pET28a-1593 harboring single or double or triple 
mutation(s) was used as a template following the same 
protocol as above.
Protein overexpression and purification
Wild-type cADO 1593 and the mutants were overex-
pressed in E. coli BL21(DE3) following the published pro-
cedure [13]. The plasmids were transformed into E. coli 
BL21(DE3) competent cells. Terrific broth media at 37 °C 
was utilized for protein expression. The cultures were 
induced with 1 mM IPTG supplemented with 50 μM fer-
rous ammonium sulfate and 50 μg/mL kanamycin when 
OD600nm reached around 0.6. The cells were continuously 
grown for additional 3.5 hours before being harvested at 
37 °C, 220 rpm. The cultures were then disrupted by son-
ication in binding buffer The recombinant protein was 
washed using binding buffers containing a gradient (30 to 
250  mM imidazole) at 4  °C. SDS-PAGE was performed 
in 12 % polyacrylamide gel using Coomassie Blue R-250 
staining. The buffer containing 1 mM EDTA and 1 mM 
NTA was utilized to dialyze the protein for preparing 
apo-cADO-1593, and stoichiometric amounts of ferrous 
ammonium sulfate was added to reconstitute the difer-
rous form of cADO-1593 prior to assay. Proteins were 
concentrated and the concentration was determined by 
the Bradford method using bovine serum albumin as a 
standard [36].
Synthesis of C14,16,18 aldehydes
According to the published procedure, C14,16,18 aldehydes 
were synthesized, respectively using the corresponding 
fatty alcohols as the starting materials [11, 37]. The syn-
thesized products were confirmed by GC–MS.
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Enzyme assay
According to the published procedure [13], assays were 
carried out in HEPES buffer, containing 100 mM KCl and 
100 mM HEPES, pH 7.2 (Additional files 4, 10). The reac-
tion mixtures contain NADH (750 μM), catalase (1 mg/
mL), ferrous ammonium sulfate (80 μM), PMS (75 μM), 
appropriate amount of aldehydes (150 μM for C12,14,16,18 
aldehydes, 2 mM for C4,6,7,9,10 aldehydes), cADO (10 μM 
for n-decanal, 20 μM for ≥C12 aldehydes, 2 μM for ≤C9 
aldehydes). n-Eicosane (10  μM) was used as an internal 
standard for nonvolatile C11,13,15,17 alkanes. Ethyl acetate 
(500 μL) was then added to terminate and to extract the 
reactions for C10,12,14,16,18 aldehydes after being vibrated 
by Vortex-Genie 2 for 1 hour at 37 °C. A 400 μL extract-
ant was then analysed by GC–MS. All kinetic assays were 
carried out in triplicate.
Quantitation of nonvolatile C11,13,15,17 alkanes by gas 
chromatography‑mass spectrometry (GC–MS)
Quantification of nonvolatile C11,13,15,17 alkanes was per-
formed by gas chromatography-mass spectrometry (GC–
MS). GC–MS analysis was performed on an Agilent 7890A 
gas chromatograph equipped with a split/split less capil-
lary inlet, an Agilent 5975C GC/MSD with Triple-Axis 
Detector and an Agilent 7683B automatic liquid sampler 
(ALS). A HP-WAX column (30 m × 0.25 mm × 0.25 µm) 
was utilized with the following oven temperature program: 
40 °C held for 5 minutes, to 240 °C at 25 °C min−1, and held 
for 15 minutes. The injector temperature was 250 °C (split 
less injection), and the carrier gas employed was helium at 
a flow rate of 1 mL min−1.
Gas chromatography detection of volatile C3,5,6,7,8 alkanes
The C3,5,6,7,8 alkane products were quantified by detect-
ing headspace of the reactions using gas chromatography 
(GC). At time intervals (0, 1, 2.5, 5, 7.5 min for >C4 alde-
hydes and 0, 1, 2.5, 3.5, 5  min for n-butanal), the reac-
tions were terminated by being laid on ice. The mixtures 
were shaken at 37 °C and 200 rpm unless specified other-
wise. Reactions of propane and pentane were performed 
at room temperature without being shaken due to their 
low boiling point. All assays were performed in triplicate.
Detection and quantification of the alkane products 
were performed on a Varian 3800 GC equipped with a HP-
INNOWAX column (30  m ×  0.25  mm ×  0.25  μm). The 
column temperature was programmed as follows: 63  °C 
held for 6 minutes (for detection of propane and pentane) 
and 63 °C held for 1 minute, to 120 °C at 20 °C min−1 (for 
detection of n-hexane, n-heptane and n-octane). FID tem-
perature was set at 200  °C and the injector temperature 
was 200 °C (20:1 split). The carrier gas helium was at a flow 
rate of 1 mL min−1. Pure alkane standards were utilized to 
identify and quantitation of each alkane.
Fatty alk(a/e)ne production and analysis in genetically 
engineered E. coli strains
A single colony was cultured in LB medium overnight 
and then inoculated into modified mineral medium at 
30 °C [1]. Cells were grown in the presence of kanamycin 
(25 mg/mL for pLB1593-acr1 and pLB1593-V184F-acr1), 
ampicillin (50  mg/mL for pKC11) and chloramphenicol 
(17  mg/mL for pAL143). PBAD promoter and PT7 were, 
respectively induced with 0.4 % l-arabinose and 0.5 mM 
isopropyl β-d-thiogalactoside at an OD600nm of 0.6–0.8. 
Cell cultures were induced for 24 hours.
Cell cultures were then mixed thoroughly with equiva-
lent volume of chloroform–methanol (v/v, 2:1), together 
with n-pentadecanol, n-eicosane and n-heptadecanoic acid 
as internal standards [34]. As described earlier, cells were 
prepared and analyzed for alk(a/e)ne production [34]. The 
temperature of the injector was set at 250 °C and the col-
umn temperature was programmed as follows:100  °C for 
1 minute, then increase of 5 °C/min to 200 °C and increase 
of 25 °C/min to 240 °C and held for 15 minutes.
Circular dichroism spectroscopy
Far-UV CD spectra (190 to 260  nm) were measured 
for protein samples (0.12  mg/mL) in 10  mM potassium 
phosphate buffer (pH 7.2) on a Jasco J-810 spectropola-
rimeter at 25 °C. Data were averaged over three runs and 
the background was subtracted.
Secondary-structure analyses were performed with 
BeStSel method [38], which is available at the bestsel.elte.
hu server.
Substrate competition assays for some engineered 
proteins and WT
In the substrate competition assays, the preferred sub-
strates for the mutants were added together with a 
shorter- or longer-chain one as the competition substrate.
For mutants A121F and I24Y, n-heptanal (2  mM) was 
added together with equal molar n-butanal or n-octadeca-
nal (150  μM). The apparent kcat values of the engineered 
proteins for n-heptanal were determined as above. n-Octa-
nal and n-nonanal were, respectively employed to evaluate 
the substrate preference for M193Y and L198F in the same 
way. In the assays for mutants V184F, F87Y, I27F and V28Y, 
n-dodecanal was used together with n-heptanal (2 mM) or 
n-octadecanal (150  μM). n-Decane was employed as an 
internal standard to evaluate the production of n-unde-
cane. The composition of the reaction mixture and reac-
tion time were same as those in enzyme assays.
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